ATMPs: Regulatory Do’s and Don’ts

Peter Fry is Regulatory Affairs Director at QbD Group Ltd and has over 20 years’ experience in the pharmaceutical industry. Whilst at QbD, he has provided strategic and operational regulatory affairs support to clients on a variety of projects across the product lifecycle, with a particular focus on the area of chemistry, manufacturing and controls (CMC).

 

Peter is a member of the ATMP core team within the QbD Group. This consists of highly skilled professionals in the different aspects and steps of the ATMP product lifecycle across process development, manufacturing, quality control, regulatory affairs and quality management, helping clients establish or improve their product manufacturing and control strategy.

 

Peter gained his degree in Chemistry from the University of Bristol and during the early part of his career worked in Medicinal Chemistry, with his main area of focus the research and development of novel drug substances for the potential treatment of diabetes and obesity.